Grazia Graziani

8.2k total citations
197 papers, 6.3k citations indexed

About

Grazia Graziani is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Grazia Graziani has authored 197 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 92 papers in Oncology and 36 papers in Immunology. Recurrent topics in Grazia Graziani's work include PARP inhibition in cancer therapy (40 papers), DNA Repair Mechanisms (31 papers) and Angiogenesis and VEGF in Cancer (21 papers). Grazia Graziani is often cited by papers focused on PARP inhibition in cancer therapy (40 papers), DNA Repair Mechanisms (31 papers) and Angiogenesis and VEGF in Cancer (21 papers). Grazia Graziani collaborates with scholars based in Italy, United States and France. Grazia Graziani's co-authors include Lucio Tentori, Pedro Miguel Lacal, Isabella Faraoni, Enzo Bonmassar, Claudia Ceci, Pierluigi Navarra, Stefania D’Atri, Ilaria Portarena, Maria Grazia Atzori and Alessia Muzi and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Grazia Graziani

194 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grazia Graziani Italy 43 3.6k 2.6k 890 759 702 197 6.3k
Alexandru Almasan United States 45 4.4k 1.2× 1.9k 0.7× 951 1.1× 485 0.6× 1.0k 1.4× 96 6.5k
Agostino Tafuri Italy 36 4.3k 1.2× 1.7k 0.6× 2.3k 2.6× 631 0.8× 787 1.1× 160 8.3k
Aviv Gazit Israel 45 5.3k 1.5× 3.3k 1.2× 1.3k 1.4× 920 1.2× 913 1.3× 99 9.7k
Wayne A. Phillips Australia 43 4.1k 1.1× 2.3k 0.9× 1.0k 1.1× 479 0.6× 1.3k 1.8× 169 7.2k
Didier Decaudin France 39 3.6k 1.0× 1.8k 0.7× 1.2k 1.3× 346 0.5× 765 1.1× 148 7.0k
Guy Laurent France 49 3.9k 1.1× 1.8k 0.7× 1.5k 1.7× 695 0.9× 453 0.6× 197 7.3k
Gÿorgý Kéri Hungary 41 3.5k 1.0× 1.7k 0.6× 479 0.5× 357 0.5× 535 0.8× 162 6.1k
Peter T. Daniel Germany 53 5.2k 1.5× 2.8k 1.0× 1.8k 2.1× 380 0.5× 1.0k 1.5× 135 8.2k
Gerhard Fritz Germany 45 3.9k 1.1× 1.8k 0.7× 735 0.8× 277 0.4× 1.3k 1.8× 136 6.7k
Ching-Shih Chen United States 46 3.3k 0.9× 920 0.3× 533 0.6× 491 0.6× 652 0.9× 83 5.3k

Countries citing papers authored by Grazia Graziani

Since Specialization
Citations

This map shows the geographic impact of Grazia Graziani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grazia Graziani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grazia Graziani more than expected).

Fields of papers citing papers by Grazia Graziani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grazia Graziani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grazia Graziani. The network helps show where Grazia Graziani may publish in the future.

Co-authorship network of co-authors of Grazia Graziani

This figure shows the co-authorship network connecting the top 25 collaborators of Grazia Graziani. A scholar is included among the top collaborators of Grazia Graziani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grazia Graziani. Grazia Graziani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucarini, Elena, Carmen Parisio, Elisabetta Gerace, et al.. (2025). The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effects. Neurotherapeutics. 22(2). e00532–e00532. 1 indexed citations
2.
Ottone, Tiziana, et al.. (2024). Combination Treatment of Resistant Acute Promyelocytic Leukemia Cells with Arsenic Trioxide and Anti-Apoptotic Gene Inhibitors. Pharmaceuticals. 17(11). 1529–1529. 1 indexed citations
3.
Ceci, Claudia, Federica Ruffini, Mattia Falconi, et al.. (2024). Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential. Biomedicine & Pharmacotherapy. 176. 116766–116766. 5 indexed citations
4.
López‐Ortiz, Susana, José Pinto-Fraga, Pedro L. Valenzuela, et al.. (2023). Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review. Cancers. 15(1). 324–324. 23 indexed citations
5.
Maresca, Carmen, C. D’Angelo, Eleonora Petti, et al.. (2023). PARP1 allows proper telomere replication through TRF1 poly (ADP-ribosyl)ation and helicase recruitment. Communications Biology. 6(1). 234–234. 14 indexed citations
6.
Tundo, Grazia Raffaella, Giuseppe Grasso, Marco Persico, et al.. (2023). The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Biomolecules. 13(10). 1492–1492. 8 indexed citations
7.
Franzese, Ornella & Grazia Graziani. (2022). Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints. Cancers. 14(22). 5633–5633. 20 indexed citations
8.
Tundo, Grazia Raffaella, Paolo Cascio, Danilo Milardi, et al.. (2022). Targeting immunoproteasome in neurodegeneration: A glance to the future. Pharmacology & Therapeutics. 241. 108329–108329. 8 indexed citations
9.
Bavetta, Mauro, Elena Campione, Pietro Sollena, et al.. (2021). The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions. Journal of Clinical Medicine. 10(3). 466–466. 7 indexed citations
10.
Faraoni, Isabella, et al.. (2021). High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients. Cancers. 13(6). 1428–1428. 22 indexed citations
11.
Prete, Salvatore Pasquale, Tiziana Ottone, Fabio Ciccarone, et al.. (2021). Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C. Journal of Pharmacology and Experimental Therapeutics. 377(3). 385–397. 9 indexed citations
12.
Ceci, Claudia, Maria Grazia Atzori, Pedro Miguel Lacal, & Grazia Graziani. (2020). Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma. Cancers. 12(11). 3401–3401. 58 indexed citations
13.
Ciotti, Gabriella Maria Pia, Francesco Canonico, Fabio Altieri, et al.. (2020). PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation. International Journal of Molecular Sciences. 21(21). 8214–8214. 29 indexed citations
14.
Ceci, Claudia, Maria Grazia Atzori, Pedro Miguel Lacal, & Grazia Graziani. (2020). Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models. International Journal of Molecular Sciences. 21(4). 1388–1388. 160 indexed citations
15.
Faraoni, Isabella, Maria Irno Consalvo, Emiliano Fabiani, et al.. (2019). Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes. Cancers. 11(9). 1373–1373. 16 indexed citations
16.
Ceci, Claudia, et al.. (2018). Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid. Nutrients. 10(11). 1756–1756. 194 indexed citations
17.
Ceci, Claudia, Lucio Tentori, Maria Grazia Atzori, et al.. (2016). Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth. Nutrients. 8(11). 744–744. 83 indexed citations
18.
Graziani, Grazia, Lucio Tentori, Alessia Muzi, et al.. (2006). Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Molecular and Cellular Endocrinology. 264(1-2). 44–49. 46 indexed citations
19.
D’Atri, Stefania, Ester Alvino, Maria Tricarico, et al.. (1992). Chemical xenogenization (CX) of cancer cells by triazene compounds: Studies with leukemia and melanoma cells. 2(3). 457–459. 1 indexed citations
20.
Eva, Alessandra, et al.. (1991). Dominant dysplasia of the lens in transgenic mice expressing the dbl oncogene.. PubMed. 3(2). 158–68. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandru Almasan Breakdown of academic impact, for papers by Agostino Tafuri Breakdown of academic impact, for papers by Aviv Gazit Breakdown of academic impact, for papers by Wayne A. Phillips Breakdown of academic impact, for papers by Didier Decaudin Breakdown of academic impact, for papers by Guy Laurent Breakdown of academic impact, for papers by Gÿorgý Kéri Breakdown of academic impact, for papers by Peter T. Daniel Breakdown of academic impact, for papers by Gerhard Fritz Breakdown of academic impact, for papers by Ching-Shih Chen
Rankless by CCL
2026